| 12/12/2025 | BK | Market Commentary: Sazerac, AL GCX, Jennmar, BradyPLUS, Victoria’s Secret, Centuri, Lumexa, Bausch break
|
| 12/11/2025 | BK | Market Commentary: Mariner, Convergint, Omnia, Carroll break; Wesco, Lumexa, Bausch + Lomb changes emerge
|
| 12/11/2025 | BK | Bausch + Lomb lifts term loan B due 2031 to $2.81 billion, firms at SOFR plus 375 bps
|
| 12/8/2025 | BK | Market Commentary: Aramark, Kaseya, Sauer break; Jones DesLauriers tweaked; US Fertility, Kestra accelerated
|
| 12/8/2025 | BK | Bausch + Lomb launches $2.32 billion term B at SOFR plus 375-400 bps
|
| 6/27/2025 | BK | Bausch + Lomb revamps credit agreement, ups revolver to $800 million
|
| 6/18/2025 | BK | Market Commentary: Proofpoint, Prometric, Inmar, Six Flags, Bausch + Lomb, Altera term loans break for trading
|
| 6/17/2025 | BK | Market Commentary: Beacon, Hill Top, Crystal, Creative, SomniGroup break; Altera, Prometric, Bausch revised
|
| 6/17/2025 | BK | Bausch + Lomb ups term B to $2.33 billion, firms at SOFR plus 425 bps
|
| 6/16/2025 | BK | Market Commentary: Astoria breaks; Altera, Prometric, Bausch accelerated; Sazerac, Nexstar and more set talk
|
| 6/11/2025 | BKCADDHY | Fitch rates Bausch + Lomb loan, notes BB
|
| 6/10/2025 | BK | Market Commentary: Student Transportation, Mavis, SupplyOne break; National Seating, Interstate, BGIS updated
|
| 6/10/2025 | BK | Bausch + Lomb to launch $2.2 billion term loan B on Thursday
|
| 6/10/2025 | BKCADDHY | S&P rates Bausch + Lomb loan, notes B
|
| 6/10/2025 | BKCADDHY | Moody's rates Bausch + Lomb loans, notes B1
|
| 4/17/2025 | BKCADDHY | Fitch raises Bausch + Lomb
|
| 3/20/2025 | BKCADDHY | Moody's gives Bausch loans, notes Caa1
|
| 3/19/2025 | BKCADDHY | S&P hikes Bausch + Lomb
|
| 12/12/2024 | BKCADDHY | Bausch + Lomb mum in comment on deal negotiations for potential sale
|
| 11/1/2024 | BK | Bausch + Lomb borrows $400 million in second incremental term loans
|
| 10/3/2023 | BKDDHY | Fitch lowers Bausch Health debt
|
| 9/15/2023 | BKCVDDEMIGPV | Market Commentary: Junk marks busiest week of year; calendar eyed; Bausch + Lomb, Freedom Mortgage outperform
|
| 9/14/2023 | BK | Market Commentary: Nomad, Flynn, USI, Bausch break; AerCap, Creative Artists, Nouryon, Pacific Dental updated
|
| 9/14/2023 | BKCVDDEMIGPV | Market Commentary: High yield: Bausch + Lomb, Freedom price; Greenfire outperforms; funds gain $81 million
|
| 9/13/2023 | BK | Market Commentary: Tamko Building breaks; American Airlines softens; Iridium, USI, Bausch, AerCap updated
|
| 9/13/2023 | BK | Bausch + Lomb tightens $500 million term loan B OID to 99
|
| 9/11/2023 | BKCVDDEMIGPV | Market Commentary: Primary prices $2.3 billion in five tranches; Bausch + Lomb on deck
|
| 9/11/2023 | BK | Market Commentary: Charter lifted with Disney agreement; Forward Air, Fogo de Chao, USI and more set talk
|
| 9/11/2023 | BKCAHY | Moody's gives Bausch+Lomb loan, notes B1
|
| 9/11/2023 | BKCAHY | S&P rates Bausch + Lomb loan, notes B-
|
| 9/11/2023 | BK | Bausch + Lomb to launch $500 million term loan B on Tuesday
|
| 9/6/2023 | BKCAHY | Bausch + Lomb outlines new debt for purchase of Novartis assets
|
| 8/31/2023 | BKCVDDEMIGPV | Market Commentary: Junk shadow calendar eyed; Clear Channel notes above par; funds see $311 million inflow
|
| 7/3/2023 | BK | Market Commentary: Bausch + Lomb recoups some losses after last week’s dip on debt financed acquisition news
|
| 6/30/2023 | BK | Market Commentary: Bausch + Lomb softens in trading with planned debt financed acquisition; Lackawanna on deck
|
| 6/30/2023 | BKCAHY | Bausch + Lomb plans new debt for purchase of Novartis assets
|
| 10/7/2022 | BK | Fitch downgrades Bausch + Lomb
|
| 10/4/2022 | BKCADD | S&P moves Bausch + Lomb view to positive
|
| 9/30/2022 | BKCACVDDHY | Moody's cuts some Bausch Health ratings
|
| 8/31/2022 | BKCADDHY | Moody's cuts Bausch Health
|
| 8/3/2022 | BKCVHY | Fitch cuts Bausch + Lomb
|
| 8/1/2022 | BKCACVHY | S&P lowers Bausch + Lomb
|
| 7/29/2022 | BKCACVHY | Moody's downgrades Bausch Health
|
| 5/31/2022 | BK | S&P nips Bausch + Lomb
|
| 5/13/2022 | BKCAHY | Moody's downgrades Bausch Health
|
